The labeling warns that concomitant use with insulin or an insulin secretagogue may increase hypoglycemia risk, including severe hypoglycemia, and separately warns about acute kidney injury due to volume depletion in patients with adverse reactions such as vomiting or diarrhea
Research indicates that gastrointestinal side effects typically become much more tolerable after the first few months of semaglutide, with the prevalence of nausea, diarrhoea and vomiting peaking around week 20 and decreasing thereafter
Semaglutide | Interactions BNF NICE
These lawsuits allege that Novo Nordisk failed to warn patients and physicians of these risks, which has led to significant health problems and a decreased quality of life for many users
The evaluation is personalized and judgment-free
For those uncomfortable injecting themselves or that find a daily pill more compatible with their life, todays announcement could be life-changing, he said